If you have taken an antidepressant, given it a fair trial, and still feel the weight of depression, it is easy to conclude that nothing will work and that the problem is you. Neither is true. When depression does not respond to two or more adequate treatments, clinicians have a specific term for it, treatment-resistant depression, and naming it matters, because it comes with its own well-mapped set of next steps.
What treatment-resistant actually means
The phrase sounds final, but it is really just a signpost. It generally means that two different antidepressants, each taken at a proper dose for a proper length of time, have not brought enough relief. That is a common situation, not a rare failure. It does not mean your depression is untreatable. It means the standard first moves were not the right fit, and it is time to widen the search.
Reframe the label
Treatment-resistant does not mean you resisted treatment, and it does not mean you are a difficult case. It means the illness has not yet met the treatment that helps it. For many people, that treatment exists. It simply was not the first or second thing tried.
Before concluding anything, a good clinician checks the basics
Sometimes what looks like resistance is something more fixable underneath:
- Was the trial adequate? The right dose, for long enough, actually taken as prescribed.
- Is the diagnosis complete? Conditions like bipolar disorder, thyroid problems, or chronic pain can change the picture and the plan.
- Is anything else in the way? Alcohol, other medications, sleep disorders, and untreated anxiety can all blunt a treatment's effect.
Working through this list is not busywork. It often reveals a straightforward reason a treatment underperformed, and a clear adjustment.
Where the path leads next
When the basics check out and depression persists, the options broaden rather than run out:
- Adjusting or combining medications, including adding a second medicine that boosts the first.
- Adding structured therapy, such as CBT, which pairs well with medication.
- Esketamine (Spravato), a monitored nasal-spray treatment approved specifically for depression that has not responded to other options.
- TMS therapy, a drug-free, magnetic treatment delivered in short daily sessions.
These are not experimental last resorts. Esketamine and TMS are both FDA-authorized, delivered in clinics every day, and covered by most insurance. They exist precisely for this moment, when the first attempts have not been enough.
Running out of first options is not the same as running out of options. It is usually the point where the more powerful ones come into view.
What to do with this
If you are here because the first things did not work, the most useful next step is a conversation with a clinician who treats depression at this level, ideally one who offers the full range, from medication management to esketamine and TMS. Bring an honest history of what you have tried and how it went. That history is not a record of failure. It is the map that points to what to try next.